Related Experiment Video
Updated: Jul 4, 2026
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
A Case of Transcatheter Aortic Valve Implantation in a Centenarian Patient
Salem Badr1, Daniel O Johnsrud1, Charnai D Sherry1
1Aurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St. Luke's Medical Centers, 2801 W. Kinnickinnic River Parkway, Ste. 880, Milwaukee, WI 53215, USA.
Insights
Transcatheter aortic valve implantation (TAVI) offers a new treatment for severe aortic stenosis in elderly patients. This study details the successful TAVI procedure in the oldest patient reported, aged 100 years, expanding treatment options for this demographic.
Area of Science:
- Cardiology
- Interventional Cardiology
- Geriatric Medicine
Background:
- Calcified aortic stenosis is the most prevalent acquired valvular heart disease in the elderly.
- Traditional surgical valve replacement carries high mortality risks (>10%) for patients over 90.
- Transcatheter aortic valve implantation (TAVI) is an emerging alternative for severe aortic stenosis.
Observation:
- Data on TAVI outcomes in centenarians (patients >100 years) is scarce.
- This report focuses on the oldest patient documented to have undergone successful TAVI.
- The patient was over 100 years old at the time of the procedure.
Findings:
- Successful transcatheter aortic valve implantation (TAVI) was performed on the oldest reported patient.
- The procedure demonstrated feasibility and positive outcomes in extreme elderly patients.
- This case highlights TAVI's potential in a previously underrepresented age group.
Implications:
- TAVI may be a viable therapeutic option for nonagenarians and centenarians with severe aortic stenosis.
- Further research is warranted to establish TAVI's safety and efficacy in the oldest populations.
- This case expands the understanding of TAVI's applicability in advanced age, improving quality of life.
Abstract:
Calcified aortic stenosis has become the most common form of acquired valvular heart disease in very old patients. Despite this fact, a majority of these patients were turned down by surgery owing to a risk of mortality > 10% in patients older than 90 years. In recent years, transcatheter aortic valve implantation (TAVI) has emerged as a therapeutic option for severe aortic stenosis. However, there is a paucity of data regarding the outcomes of TAVI in patients older than 100 years. We present the oldest patient who has undergone successful TAVI reported in the current literature.
More Related Videos
05:31Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
06:04Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
